Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up

加强结肠癌筛查和随访的支持系统 (SOS)

基本信息

项目摘要

DESCRIPTION (provided by applicant): The lifetime risk of colorectal cancer is over 5% in the United States where, despite recent declines in incidence and mortality, colorectal cancer remains the second highest cause of cancer death. Better treatments have improved survival rates, but morbidity and mortality could be more rapidly and cost-effectively reduced by achieving higher uptake and long-term adherence to colorectal cancer screening. The Systems of Support to Decrease Colorectal Cancer (SOS) study successfully advanced colorectal screening. SOS was a 4-arm randomized controlled trial that leveraged electronic health record data and automated systems to implement stepwise increases in screening support. Patients due for screening (n=4675) were randomized to (1) Usual Care, (2) Automated care (automated mailings and fecal occult blood tests), (3) automated plus assisted care from medical assistants (phone reminders and sending orders to physicians to sign), or (4) automated + assisted + navigated care from registered nurses (follow-up until test completion). Interventions were repeated in year 2. Compared to usual care, intervention patients were more likely to be current for colorectal cancer screening in both study years, with increases by intervention intensity: Usual Care 26.5%, Automated 50.7%, Assisted 57.7%, and Navigated 64.4% (P<.001). We propose to improve and continue SOS interventions up to 10 years and measure their effects on long-term adherence and outcomes. We will: 1. Identify factors related to low or non-adherence to screening despite receiving continued interventions and apply these findings to a stepped intervention to increase uptake and long-term adherence of screening. 2. Assess the effectiveness of the SOS interventions on long-term screening adherence up to 10 years. 3. Describe the impact of SOS interventions on colorectal cancer-related costs and clinical outcomes.
描述(由申请人提供):在美国,结直肠癌的终生风险超过5%,尽管最近发病率和死亡率有所下降,但结直肠癌仍然是癌症死亡的第二大原因。更好的治疗方法提高了生存率,但发病率和死亡率可以通过提高对结直肠癌筛查的接受程度和长期坚持来更快、更经济地降低。支持系统减少结直肠癌(SOS)研究成功推进结直肠癌筛查。SOS是一项四组随机对照试验,利用电子健康记录数据和自动化系统逐步增加筛查支持。拟进行筛查的患者(n=4675)随机分为(1)常规护理,(2)自动护理(自动邮寄和粪便隐血检查),(3)医疗助理的自动加辅助护理(电话提醒和发送命令给医生签名),或(4)注册护士的自动+辅助+导航护理(随访直到测试完成)。在第二年重复干预。与常规护理相比,干预患者在两个研究年份都更有可能进行结直肠癌筛查,干预强度增加:常规护理26.5%,自动化50.7%,辅助57.7%,导航64.4% (P< 0.001)。我们建议改进并持续SOS干预长达10年,并测量其对长期依从性和结果的影响。我们将:1;确定在接受持续干预后仍低依从性或不依从性筛查的相关因素,并将这些发现应用于阶梯式干预,以增加筛查的吸收和长期依从性。2. 评估SOS干预措施对长达10年的长期筛查依从性的有效性。3. 描述SOS干预对结直肠癌相关费用和临床结果的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Beverly Beth Green其他文献

Beverly Beth Green的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Beverly Beth Green', 18)}}的其他基金

Self-Testing Options in the era of Primary HPV screening for cervical cancer: the STEP trial
宫颈癌初级 HPV 筛查时代的自我检测选择:STEP 试验
  • 批准号:
    10661709
  • 财政年份:
    2019
  • 资助金额:
    $ 72.15万
  • 项目类别:
Self-Testing Options in the era of Primary HPV screening for cervical cancer: the STEP trial
宫颈癌初级 HPV 筛查时代的自我检测选择:STEP 试验
  • 批准号:
    10448439
  • 财政年份:
    2019
  • 资助金额:
    $ 72.15万
  • 项目类别:
Self-Testing Options in the era of Primary HPV screening for cervical cancer: the STEP trial
宫颈癌初级 HPV 筛查时代的自我检测选择:STEP 试验
  • 批准号:
    10216202
  • 财政年份:
    2019
  • 资助金额:
    $ 72.15万
  • 项目类别:
Collaborative Behavioral e-Care to Decrease Cardiovascular Risk (e-Compare)
协作行为电子护理可降低心血管风险(电子比较)
  • 批准号:
    7937755
  • 财政年份:
    2009
  • 资助金额:
    $ 72.15万
  • 项目类别:
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up
加强结肠癌筛查和随访的支持系统 (SOS)
  • 批准号:
    7909655
  • 财政年份:
    2009
  • 资助金额:
    $ 72.15万
  • 项目类别:
Collaborative Behavioral e-Care to Decrease Cardiovascular Risk (e-Compare)
协作行为电子护理可降低心血管风险(电子比较)
  • 批准号:
    7833997
  • 财政年份:
    2009
  • 资助金额:
    $ 72.15万
  • 项目类别:
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up
加强结肠癌筛查和随访的支持系统 (SOS)
  • 批准号:
    8105785
  • 财政年份:
    2007
  • 资助金额:
    $ 72.15万
  • 项目类别:
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up
加强结肠癌筛查和随访的支持系统 (SOS)
  • 批准号:
    8470772
  • 财政年份:
    2007
  • 资助金额:
    $ 72.15万
  • 项目类别:
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up
加强结肠癌筛查和随访的支持系统 (SOS)
  • 批准号:
    8705421
  • 财政年份:
    2007
  • 资助金额:
    $ 72.15万
  • 项目类别:
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up
加强结肠癌筛查和随访的支持系统 (SOS)
  • 批准号:
    8870306
  • 财政年份:
    2007
  • 资助金额:
    $ 72.15万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 72.15万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了